Streptolysin O derived from Streptococcus pyogenes inhibits RANKL‑induced osteoclastogenesis through the NF‑κB signaling pathway

Yi,Jin; Tang,Ruohui; Yang,Jing; Chen,Yueqi; Fei,Jun

doi:10.3892/mmr.2018.9662

Streptolysin O derived from Streptococcus pyogenes inhibits RANKL‑induced osteoclastogenesis through the NF‑κB signaling pathway

Authors:
- Jin Yi
- Ruohui Tang
- Jing Yang
- Yueqi Chen
- Jun Fei
View Affiliations

Affiliations: Centre of Trauma of PLA, Daping Hospital, Third Military Medical University, Chongqing 400042, P.R. China, Department of Biomedical Materials Science, School of Biomedical Engineering, Third Military Medical University, Chongqing 400038, P.R. China
Published online on: November 15, 2018 https://doi.org/10.3892/mmr.2018.9662
Pages: 414-422
Copyright: © Yi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Streptococcus pyogenes (GAS) is a clinically significant bacterial strain that causes bacterial arthritis, osteomyelitis and implant infections. Infection complications can lead to serious bone destruction. Osteoclasts, the only type of cell with bone resorption function, participate in this process. Streptolysin O (SLO) is produced by almost all clinical Streptococcus pyogenes isolates. However, the role of SLO in bone infection caused by GAS had not been previously examined. The current study was performed to define the effects of SLO on receptor activator of NF‑κB ligand‑stimulated osteoclast differentiation in vitro. Results demonstrated that SLO decreased the phosphorylation of p65 and NF‑κB inhibitor α, suppressed c‑FOS and nuclear factor of activated T‑cells cytoplasmic 1, and downregulated the expression of osteoclast marker genes. SLO also induced apoptosis of mature osteoclasts. The results suggested that SLO blocked osteoclast activation during GAS infection. These findings may prove useful in the development of novel strategies for treating GAS‑associated bone infectious diseases.

View Figures

View References

1	Harada S and Rodan GA: Control of osteoblast function and regulation of bone mass. Nature. 423:349–355. 2003. View Article : Google Scholar : PubMed/NCBI
2	Kim J, Yang J, Park OJ, Kang SS, Kim WS, Kurokawa K, Yun CH, Kim HH, Lee BL and Han SH: Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. J Bone Miner Res. 28:2381–2391. 2013. View Article : Google Scholar : PubMed/NCBI
3	Moriarty TF, Schlegel U, Perren S and Richards RG: Infection in fracture fixation: Can we influence infection rates through implant design? J Mater Sci Mater Med. 21:1031–1035. 2010. View Article : Google Scholar : PubMed/NCBI
4	Schattner A and Vosti KL: Bacterial arthritis due to beta-hemolytic streptococci of serogroups A, B, C, F and G: Analysis of 23 cases and a review of the literature. Medicine (Baltimore). 77:122–139. 1998. View Article : Google Scholar : PubMed/NCBI
5	Pichichero ME and Casey JR: Systematic review of factors contributing topenicillin treatment failure in Streptococcus pyogenes pharyngitis. Otolaryngol Head Neck Surg. 137:851–857. 2007. View Article : Google Scholar : PubMed/NCBI
6	Nilsson M, Sørensen OE, Mörgelin M, Weineisen M, Sjöbring U and Herwald H: Activation of human polymorphonuclear eutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators. Thromb Haemost. 95:982–990. 2006. View Article : Google Scholar : PubMed/NCBI
7	Anderluh G and Lakey J: Proteins: Membrane binding and pore formation. Preface. Adv Exp Med Biol. 677:v–vi. 2010.PubMed/NCBI
8	Hotze EM, Wilson-Kubalek E, Farrand AJ, Bentsen L, Parker MW, Johnson AE and Tweten RK: Monomer-monomer interactions propagate structural transitions necessary for pore formation by the cholesterol-dependent cytolysins. J Biol Chem. 287:24534–24543. 2012. View Article : Google Scholar : PubMed/NCBI
9	Bhakdi S, Bayley H, Valeva A, Walev I, Walker B, Kehoe M and Palmer M: Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: Prototypes of pore-forming bacterial cytolysins. Arch Microbiol. 165:73–79. 1996. View Article : Google Scholar : PubMed/NCBI
10	Bricker AL, Carey VJ and Wessels MR: Role of NADase in virulence in experimental invasive group A streptococcal infection. Infect Immun. 73:6562–6566. 2005. View Article : Google Scholar : PubMed/NCBI
11	O'Seaghdha M and Wessels MR: Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from Xenophagic killing. PLoS Pathog. 9:e10033942013. View Article : Google Scholar : PubMed/NCBI
12	Bastiat-Sempe B, Love JF, Lomayesva N and Wessels MR: Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A streptococcus survival in macrophages. MBio. 5:e01690–14. 2014. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
14	Carapetis JR, Steer AC, Mulholland EK and Weber M: The global burden of group A streptococcal diseases. Lancet Infect Dis. 5:685–694. 2005. View Article : Google Scholar : PubMed/NCBI
15	Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, Sriprakash KS, Sanderson-Smith ML and Nizet V: Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev. 27:264–301. 2014. View Article : Google Scholar : PubMed/NCBI
16	Good MF, Batzloff M and Pandey M: Strategies in the development of vaccines to prevent infections with group A streptococcus. Hum Vaccin Immunother. 9:2393–2397. 2013. View Article : Google Scholar : PubMed/NCBI
17	Pichichero ME: Group A beta-hemolytic streptococcal infections. Pediatr Rev. 19:291–302. 1998. View Article : Google Scholar : PubMed/NCBI
18	Freiberg JA, Mciver KS and Shirtliff ME: In vivo expression of Streptococcus pyogenes immunogenic proteins during tibial foreign body infection. Infect Immun. 82:3891–3899. 2014. View Article : Google Scholar : PubMed/NCBI
19	Sakurai A, Okahashi N, Nakagawa I, Kawabata S, Amano A, Ooshima T and Hamada S: Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligan. Infect Immun. 71:6019–6026. 2003. View Article : Google Scholar : PubMed/NCBI
20	Matsui H, Nakatani Y, Yoshida H, Takizawa A, Takeuchi O, Øverby A, Takahashi T, Murayama SY and Matsuo K: Flesh-eating Streptococcus pyogenes triggers the expression of receptor activator of nuclear factor-κB ligand. Cell Microbiol. 18:1390–1404. 2016. View Article : Google Scholar : PubMed/NCBI
21	Okahashi N, Sakurai A, Nakagawa I, Fujiwara T, Kawabata S, Amano A and Hamada S: Infection by Streptococcus pyogenes induces the receptor activator of NF-kappaB ligand expression in mouse osteoblastic cells. Infect Immun. 71:948–955. 2003. View Article : Google Scholar : PubMed/NCBI
22	Barnes PJ and Karin M: Nuclear factor-kappsBb: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336:1066–1071. 1997. View Article : Google Scholar : PubMed/NCBI
23	Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165–176. 1998. View Article : Google Scholar : PubMed/NCBI
24	Ghosh S and Karin M: Missing pieces in the NF-kappaB puzzle. Cell. 109 Suppl:S81–S96. 2002. View Article : Google Scholar : PubMed/NCBI
25	Nepal M, Choi HJ, Choi BY, Yang MS, Chae JI, Li L and Soh Y: Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-kappaB and NFATc1 pathways. Eur J Pharmacol. 715:96–104. 2013. View Article : Google Scholar : PubMed/NCBI
26	Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, et al: NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem. 282:18245–18253. 2007. View Article : Google Scholar : PubMed/NCBI
27	Cywes Bentley C, Hakansson A, Christianson J and Wessels MR: Extracellular group A Streptococcus induces keratinocyte apoptosis by dysregulating calcium signaling. Cell Microbiol. 7:945–955. 2005. View Article : Google Scholar : PubMed/NCBI
28	Timmer AM, Timmer JC, Pence MA, Hsu LC, Ghochani M, Frey TG, Karin M, Salvesen GS and Nizet V: Streptolysin O promotes group A Streptococcus immune evasion by accelerated macrophage apoptosis. J Biol Chem. 284:862–871. 2009. View Article : Google Scholar : PubMed/NCBI
29	Scorrano L and Korsmeyer SJ: Mechanisms of cytochrome c release by proapoptotic Bcl-2 family members. Biochem Biophys Res Commun. 304:437–444. 2003. View Article : Google Scholar : PubMed/NCBI
30	Tai TW, Chen CY, Su FC, Tu YK, Tsai TT, Lin CF and Jou IM: Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells. Sci Rep. 7:442452017. View Article : Google Scholar : PubMed/NCBI
31	Kinning E, McMillan M, Shepherd S, Helfrich M, Hof RV, Adams C, Read H, Wall DM and Ahmed SF: An unbalanced rearrangement of chromosomes 4: 20 is associated with childhood osteoporosis and reduced caspase-3 levels. J Pediatr Genet. 5:167–173. 2016. View Article : Google Scholar : PubMed/NCBI
32	Shan RF, Zhou YF, Peng AF and Jie ZG: Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-kB signaling pathway in vitro. Exp Ther Med. 8:1005–1009. 2014. View Article : Google Scholar : PubMed/NCBI
33	Nehra R, Riggins RB, Shajahan AN, Zwart A, Crawford AC and Clarke R: BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and-resistant breast cancer cells. FASEB J. 24:2040–2055. 2010. View Article : Google Scholar : PubMed/NCBI
34	Henrotin Y, Clutterbuck AL, Allaway D, Lodwig EM, Harris P, Mathy-Hartert M, Shakibaei M and Mobasheri A: Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage. 18:141–149. 2010. View Article : Google Scholar : PubMed/NCBI
35	Kiekow CJ, Figueiró F, Dietrich F, Vechia LD, Pires EN, Jandrey EH, Gnoatto SC, Salbego CG, Battastini AM and Gosmann G: Quercetin derivative induces cell death in glioma cells by modulating NF-κB nuclear translocation and Caspase-3 activation. Eur J Pharm Sci. 84:116–122. 2016. View Article : Google Scholar : PubMed/NCBI
36	Cortés G and Wessels MR: Inhibition of dendritic cell maturation by group A Streptococcus. J Infect Dis. 200:1152–1161. 2009. View Article : Google Scholar : PubMed/NCBI
37	Walev I, Hombach M, Bobkiewicz W, Fenske D, Bhakdi S and Husmann M: Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappaB activation and downstream events. FASEB J. 16:237–239. 2002. View Article : Google Scholar : PubMed/NCBI
38	Lorenzo J: Interactions between immune and bone cells: New insights with many remaining questions. J Clin Invest. 106:749–752. 2000. View Article : Google Scholar : PubMed/NCBI